Cetirizine use in childhood: An update of a friendly 30-year drug

Giuseppe Fabio Parisi; Salvatore Leonardi; Giorgio Ciprandi; Angelo Corsico; Amelia Licari; Michele Miraglia Del Giudice; Diego Peroni; Carmelo Salpietro; Gian Luigi Marseglia

doi:10.1186/s12948-020-00118-5

Cetirizine use in childhood: An update of a friendly 30-year drug

Giuseppe Fabio Parisi, Salvatore Leonardi, Giorgio Ciprandi, Angelo Corsico, Amelia Licari, Michele Miraglia Del Giudice, Diego Peroni, Carmelo Salpietro, Gian Luigi Marseglia

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Review article › peer-review

Abstract

Cetirizine is a second-generation antihistamine, derived from the metabolism of hydroxyzine, highly specific for the H1 receptors, and with marked antiallergic properties. Although its history began more than 30 years ago, it remains one of the most used drugs in children with a leading role in the medical care of children with allergic diseases. Cetirizine use is licensed for paediatric patients for the treatment of allergic rhinitis, and chronic spontaneous urticaria, in Europe in children older than 2 years old and in the USA in children older than 6 months old. This review provides a practical update on the use of cetirizine in children and adolescents.

Original language	English
Article number	2
Journal	Clinical and Molecular Allergy
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s12948-020-00118-5
Publication status	Published - Feb 26 2020

Keywords

Adolescents
Antihistamines
Cetirizine
Children
H1 receptors
Histamine
Lactation
Pregnancy

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Molecular Biology

Access to Document

10.1186/s12948-020-00118-5

Fingerprint Dive into the research topics of 'Cetirizine use in childhood: An update of a friendly 30-year drug'. Together they form a unique fingerprint.

Cite this

Cetirizine use in childhood : An update of a friendly 30-year drug. / Parisi, Giuseppe Fabio; Leonardi, Salvatore; Ciprandi, Giorgio; Corsico, Angelo ; Licari, Amelia; Miraglia Del Giudice, Michele; Peroni, Diego; Salpietro, Carmelo; Marseglia, Gian Luigi.

In: Clinical and Molecular Allergy, Vol. 18, No. 1, 2, 26.02.2020.

Research output: Contribution to journal › Review article › peer-review

@article{4da6990758c9416d95d803fe42835dcd,

title = "Cetirizine use in childhood: An update of a friendly 30-year drug",

abstract = "Cetirizine is a second-generation antihistamine, derived from the metabolism of hydroxyzine, highly specific for the H1 receptors, and with marked antiallergic properties. Although its history began more than 30 years ago, it remains one of the most used drugs in children with a leading role in the medical care of children with allergic diseases. Cetirizine use is licensed for paediatric patients for the treatment of allergic rhinitis, and chronic spontaneous urticaria, in Europe in children older than 2 years old and in the USA in children older than 6 months old. This review provides a practical update on the use of cetirizine in children and adolescents.",

keywords = "Adolescents, Antihistamines, Cetirizine, Children, H1 receptors, Histamine, Lactation, Pregnancy",

author = "Parisi, {Giuseppe Fabio} and Salvatore Leonardi and Giorgio Ciprandi and Angelo Corsico and Amelia Licari and {Miraglia Del Giudice}, Michele and Diego Peroni and Carmelo Salpietro and Marseglia, {Gian Luigi}",

year = "2020",

month = feb,

day = "26",

doi = "10.1186/s12948-020-00118-5",

language = "English",

volume = "18",

journal = "Clinical and Molecular Allergy",

issn = "1476-7961",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Cetirizine use in childhood

T2 - An update of a friendly 30-year drug

AU - Parisi, Giuseppe Fabio

AU - Leonardi, Salvatore

AU - Ciprandi, Giorgio

AU - Corsico, Angelo

AU - Licari, Amelia

AU - Miraglia Del Giudice, Michele

AU - Peroni, Diego

AU - Salpietro, Carmelo

AU - Marseglia, Gian Luigi

PY - 2020/2/26

Y1 - 2020/2/26

N2 - Cetirizine is a second-generation antihistamine, derived from the metabolism of hydroxyzine, highly specific for the H1 receptors, and with marked antiallergic properties. Although its history began more than 30 years ago, it remains one of the most used drugs in children with a leading role in the medical care of children with allergic diseases. Cetirizine use is licensed for paediatric patients for the treatment of allergic rhinitis, and chronic spontaneous urticaria, in Europe in children older than 2 years old and in the USA in children older than 6 months old. This review provides a practical update on the use of cetirizine in children and adolescents.

AB - Cetirizine is a second-generation antihistamine, derived from the metabolism of hydroxyzine, highly specific for the H1 receptors, and with marked antiallergic properties. Although its history began more than 30 years ago, it remains one of the most used drugs in children with a leading role in the medical care of children with allergic diseases. Cetirizine use is licensed for paediatric patients for the treatment of allergic rhinitis, and chronic spontaneous urticaria, in Europe in children older than 2 years old and in the USA in children older than 6 months old. This review provides a practical update on the use of cetirizine in children and adolescents.

KW - Adolescents

KW - Antihistamines

KW - Cetirizine

KW - Children

KW - H1 receptors

KW - Histamine

KW - Lactation

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85080890611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85080890611&partnerID=8YFLogxK

U2 - 10.1186/s12948-020-00118-5

DO - 10.1186/s12948-020-00118-5

M3 - Review article

AN - SCOPUS:85080890611

VL - 18

JO - Clinical and Molecular Allergy

JF - Clinical and Molecular Allergy

SN - 1476-7961

IS - 1

M1 - 2

ER -

Cetirizine use in childhood: An update of a friendly 30-year drug

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this